Skip to main content
Erschienen in: Pediatric Cardiology 6/2017

14.06.2017 | Original Article

Earlier Pulmonary Valve Replacement in Down Syndrome Patients Following Tetralogy of Fallot Repair

verfasst von: Rachel T. Sullivan, Peter C. Frommelt, Garick D. Hill

Erschienen in: Pediatric Cardiology | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

The association between Down syndrome and pulmonary hypertension could contribute to more severe pulmonary regurgitation after tetralogy of Fallot repair and possibly earlier pulmonary valve replacement. We compared cardiac magnetic resonance measures of pulmonary regurgitation and right ventricular dilation as well as timing of pulmonary valve replacement between those with and without Down syndrome after tetralogy of Fallot repair. Review of our surgical database from 2000 to 2015 identified patients with tetralogy of Fallot with pulmonary stenosis. Those with Down syndrome were compared to those without. The primary outcome of interest was time from repair to pulmonary valve replacement. Secondary outcomes included pulmonary regurgitation and indexed right ventricular volume on cardiac magnetic resonance imaging. The cohort of 284 patients included 35 (12%) with Down syndrome. Transannular patch repair was performed in 210 (74%). Down syndrome showed greater degree of pulmonary regurgitation (55 ± 14 vs. 37 ± 16%, p = 0.01) without a significantly greater rate of right ventricular dilation (p = 0.09). In multivariable analysis, Down syndrome (HR 2.3, 95% CI 1.2–4.5, p = 0.02) and transannular patch repair (HR 5.5, 95% CI 1.7–17.6, p = 0.004) were significant risk factors for valve replacement. Those with Down syndrome had significantly lower freedom from valve replacement (p = 0.03). Down syndrome is associated with an increased degree of pulmonary regurgitation and earlier pulmonary valve replacement after tetralogy of Fallot repair. These patients require earlier assessment by cardiac magnetic resonance imaging to determine timing of pulmonary valve replacement and evaluation for and treatment of preventable causes of pulmonary hypertension.
Literatur
1.
Zurück zum Zitat Hickey EJ, Veldtman G, Bradley TJ (2009) Late risk of outcomes for adults with repaired tetralogy of Fallot from an inception cohort spanning four decades. Eur J Cardiothorac Surg 35:156–166CrossRefPubMed Hickey EJ, Veldtman G, Bradley TJ (2009) Late risk of outcomes for adults with repaired tetralogy of Fallot from an inception cohort spanning four decades. Eur J Cardiothorac Surg 35:156–166CrossRefPubMed
2.
3.
Zurück zum Zitat Fudge JC, Li S, Jaggers J et al (2010) Congenital heart surgery outcomes in Down syndrome: analysis of a national clinical database. Pediatrics 126:315–322CrossRefPubMedPubMedCentral Fudge JC, Li S, Jaggers J et al (2010) Congenital heart surgery outcomes in Down syndrome: analysis of a national clinical database. Pediatrics 126:315–322CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Dimopoulos K, Kempny A (2016) Patients with Down syndrome and congenital heart disease: survival is improving, but challenges remain. Heart 102(19):1515–1517CrossRefPubMed Dimopoulos K, Kempny A (2016) Patients with Down syndrome and congenital heart disease: survival is improving, but challenges remain. Heart 102(19):1515–1517CrossRefPubMed
5.
Zurück zum Zitat Lange R, Guenther T, Busch R, Hess J, Schreiber C (2007) The presence of Down syndrome is not a risk factor in complete atrioventricular septal defect repair. J Thorac Cardiovasc Surg 134:304–310CrossRefPubMed Lange R, Guenther T, Busch R, Hess J, Schreiber C (2007) The presence of Down syndrome is not a risk factor in complete atrioventricular septal defect repair. J Thorac Cardiovasc Surg 134:304–310CrossRefPubMed
6.
Zurück zum Zitat Evans JM, Dharmar M, Meierhenry E, Marcin JP, Raff GW (2014) Association between Down syndrome and in-hospital death among children undergoing surgery for congenital heart disease: a US population-based study. Circ Cardiovasc Qual Outcomes 7:445–452CrossRefPubMed Evans JM, Dharmar M, Meierhenry E, Marcin JP, Raff GW (2014) Association between Down syndrome and in-hospital death among children undergoing surgery for congenital heart disease: a US population-based study. Circ Cardiovasc Qual Outcomes 7:445–452CrossRefPubMed
7.
Zurück zum Zitat Reller MD, Strickland MJ, Riehle-Colarusso T, Mahle WT, Correa A (2008) Prevalence of congenital heart defects in metropolitan Atlanta, 1998–2005. J Pediatr 153:807–813CrossRefPubMedPubMedCentral Reller MD, Strickland MJ, Riehle-Colarusso T, Mahle WT, Correa A (2008) Prevalence of congenital heart defects in metropolitan Atlanta, 1998–2005. J Pediatr 153:807–813CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Hoffman JI, Kaplan S (2002) The incidence of congenital heart disease. J Am Coll Cardiol 39:1890–1900CrossRefPubMed Hoffman JI, Kaplan S (2002) The incidence of congenital heart disease. J Am Coll Cardiol 39:1890–1900CrossRefPubMed
9.
Zurück zum Zitat Murphy JG, Gersh BJ, Mair DD et al (1993) Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med 329:593–599CrossRefPubMed Murphy JG, Gersh BJ, Mair DD et al (1993) Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med 329:593–599CrossRefPubMed
10.
Zurück zum Zitat Ammash NM, Dearani JA, Burkhart HM, Connolly HM (2007) Pulmonary regurgitation after tetralogy of Fallot repair: clinical features, sequelae, and timing of pulmonary valve replacement. Congenit Heart Dis 2:386–403CrossRefPubMed Ammash NM, Dearani JA, Burkhart HM, Connolly HM (2007) Pulmonary regurgitation after tetralogy of Fallot repair: clinical features, sequelae, and timing of pulmonary valve replacement. Congenit Heart Dis 2:386–403CrossRefPubMed
11.
Zurück zum Zitat Geva T (2009) Indications and timing of pulmonary valve replacement after tetralogy of Fallot repair. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 9:11–22CrossRef Geva T (2009) Indications and timing of pulmonary valve replacement after tetralogy of Fallot repair. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 9:11–22CrossRef
12.
Zurück zum Zitat Cheung E, Wong W, Cheung Y-F (2010) Meta-analysis of pulmonary valve replacement after operative repair of tetralogy of Fallot. Am J Cardiol 106:552–557CrossRefPubMed Cheung E, Wong W, Cheung Y-F (2010) Meta-analysis of pulmonary valve replacement after operative repair of tetralogy of Fallot. Am J Cardiol 106:552–557CrossRefPubMed
13.
Zurück zum Zitat Therrien J, Provost Y, Merchant N, Williams W, Colman J, Webb G (2005) Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol 95:779–782CrossRefPubMed Therrien J, Provost Y, Merchant N, Williams W, Colman J, Webb G (2005) Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol 95:779–782CrossRefPubMed
14.
Zurück zum Zitat Tweddell J, Simpson P, Li S-H, Dunham-Ingle J, Bartz PJ, Earing MG, Pelech AN (2012) Timing and technique of pulmonary valve replacement in the patient with tetralogy of Fallot. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 15:27–33CrossRefPubMed Tweddell J, Simpson P, Li S-H, Dunham-Ingle J, Bartz PJ, Earing MG, Pelech AN (2012) Timing and technique of pulmonary valve replacement in the patient with tetralogy of Fallot. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 15:27–33CrossRefPubMed
15.
Zurück zum Zitat O’Byrne ML, Glatz AC, Mercer-Rosa L et al (2015) Trends in pulmonary valve replacement in children and adults with tetralogy of Fallot. Am J Cardiol 115:118–124CrossRefPubMed O’Byrne ML, Glatz AC, Mercer-Rosa L et al (2015) Trends in pulmonary valve replacement in children and adults with tetralogy of Fallot. Am J Cardiol 115:118–124CrossRefPubMed
16.
Zurück zum Zitat Cooney TP, Thurlbeck WM (1982) Pulmonary hypoplasia in Down’s syndrome. N Engl J Med 307:1170–1173CrossRefPubMed Cooney TP, Thurlbeck WM (1982) Pulmonary hypoplasia in Down’s syndrome. N Engl J Med 307:1170–1173CrossRefPubMed
17.
Zurück zum Zitat Fukushima H, Kosaki K, Sato R (2010) Mechanisms underlying early development of pulmonary vascular obstructive disease in Down syndrome: an imbalance in biosynthesis of thromboxane A2 and prostacyclin. Am J Med Genet A 152A:1919–1924CrossRefPubMed Fukushima H, Kosaki K, Sato R (2010) Mechanisms underlying early development of pulmonary vascular obstructive disease in Down syndrome: an imbalance in biosynthesis of thromboxane A2 and prostacyclin. Am J Med Genet A 152A:1919–1924CrossRefPubMed
18.
Zurück zum Zitat Saji T (2014) Clinical characteristics of pulmonary arterial hypertension associated with Down syndrome. Pediatr Int 56:297–303CrossRefPubMed Saji T (2014) Clinical characteristics of pulmonary arterial hypertension associated with Down syndrome. Pediatr Int 56:297–303CrossRefPubMed
19.
Zurück zum Zitat Shin YR, Jung JW, Kim NK et al (2016) Factors associated with progression of right ventricular enlargement and dysfunction after repair of tetralogy of Fallot based on serial cardiac magnetic resonance imaging. Eur J Cardiothorac Surg 50:464–469CrossRefPubMed Shin YR, Jung JW, Kim NK et al (2016) Factors associated with progression of right ventricular enlargement and dysfunction after repair of tetralogy of Fallot based on serial cardiac magnetic resonance imaging. Eur J Cardiothorac Surg 50:464–469CrossRefPubMed
Metadaten
Titel
Earlier Pulmonary Valve Replacement in Down Syndrome Patients Following Tetralogy of Fallot Repair
verfasst von
Rachel T. Sullivan
Peter C. Frommelt
Garick D. Hill
Publikationsdatum
14.06.2017
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 6/2017
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-017-1653-2

Weitere Artikel der Ausgabe 6/2017

Pediatric Cardiology 6/2017 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.